Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897898885> ?p ?o ?g. }
- W2897898885 endingPage "5662" @default.
- W2897898885 startingPage "5647" @default.
- W2897898885 abstract "Tumor-associated myeloid cells maintain immunosuppressive microenvironments within tumors. Identification of myeloid-specific receptors to modulate tumor-associated macrophage and myeloid-derived suppressor cell (MDSC) functions remains challenging. The leukocyte immunoglobulin-like receptor B (LILRB) family members are negative regulators of myeloid cell activation. We investigated how LILRB targeting could modulate tumor-associated myeloid cell function. LILRB2 antagonism inhibited receptor-mediated activation of SHP1/2 and enhanced proinflammatory responses. LILRB2 antagonism also inhibited AKT and STAT6 activation in the presence of M-CSF and IL-4. Transcriptome analysis revealed that LILRB2 antagonism altered genes involved in cell cytoskeleton remodeling, lipid/cholesterol metabolism, and endosomal sorting pathways, as well as changed differentiation gene networks associated with inflammatory myeloid cells as opposed to their alternatively activated phenotype. LILRB2 blockade effectively suppressed granulocytic MDSC and Treg infiltration and significantly promoted in vivo antitumor effects of T cell immune checkpoint inhibitors. Furthermore, LILRB2 blockade polarized tumor-infiltrating myeloid cells from non–small cell lung carcinoma tumor tissues toward an inflammatory phenotype. Our studies suggest that LILRB2 can potentially act as a myeloid immune checkpoint by reprogramming tumor-associated myeloid cells and provoking antitumor immunity." @default.
- W2897898885 created "2018-10-26" @default.
- W2897898885 creator A5007055111 @default.
- W2897898885 creator A5010967438 @default.
- W2897898885 creator A5015899022 @default.
- W2897898885 creator A5022710700 @default.
- W2897898885 creator A5027856972 @default.
- W2897898885 creator A5030272301 @default.
- W2897898885 creator A5032240853 @default.
- W2897898885 creator A5035423192 @default.
- W2897898885 creator A5042855719 @default.
- W2897898885 creator A5046881277 @default.
- W2897898885 creator A5060347349 @default.
- W2897898885 creator A5064443404 @default.
- W2897898885 creator A5067788376 @default.
- W2897898885 creator A5077956716 @default.
- W2897898885 creator A5079789292 @default.
- W2897898885 creator A5081393762 @default.
- W2897898885 creator A5082615417 @default.
- W2897898885 creator A5091226552 @default.
- W2897898885 creator A5091421622 @default.
- W2897898885 date "2018-10-22" @default.
- W2897898885 modified "2023-10-14" @default.
- W2897898885 title "Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity" @default.
- W2897898885 cites W1500665679 @default.
- W2897898885 cites W1515725948 @default.
- W2897898885 cites W1570288335 @default.
- W2897898885 cites W1573082422 @default.
- W2897898885 cites W1575233708 @default.
- W2897898885 cites W1594019233 @default.
- W2897898885 cites W1642077366 @default.
- W2897898885 cites W1923917571 @default.
- W2897898885 cites W1944352258 @default.
- W2897898885 cites W1966930760 @default.
- W2897898885 cites W1967369695 @default.
- W2897898885 cites W1971620413 @default.
- W2897898885 cites W1975158182 @default.
- W2897898885 cites W1981056356 @default.
- W2897898885 cites W1981093360 @default.
- W2897898885 cites W1983015423 @default.
- W2897898885 cites W1989698859 @default.
- W2897898885 cites W1990356891 @default.
- W2897898885 cites W1992855314 @default.
- W2897898885 cites W1999781068 @default.
- W2897898885 cites W2000374637 @default.
- W2897898885 cites W2001717792 @default.
- W2897898885 cites W2007987850 @default.
- W2897898885 cites W2011211211 @default.
- W2897898885 cites W2017056838 @default.
- W2897898885 cites W2022022565 @default.
- W2897898885 cites W2027351375 @default.
- W2897898885 cites W2031456900 @default.
- W2897898885 cites W2037501841 @default.
- W2897898885 cites W2038963685 @default.
- W2897898885 cites W2040761710 @default.
- W2897898885 cites W2049489460 @default.
- W2897898885 cites W2056502408 @default.
- W2897898885 cites W2056823054 @default.
- W2897898885 cites W2058482682 @default.
- W2897898885 cites W2059303963 @default.
- W2897898885 cites W2066709335 @default.
- W2897898885 cites W2068242732 @default.
- W2897898885 cites W2068894688 @default.
- W2897898885 cites W2069169522 @default.
- W2897898885 cites W2075704548 @default.
- W2897898885 cites W2076743146 @default.
- W2897898885 cites W2087436517 @default.
- W2897898885 cites W2113082145 @default.
- W2897898885 cites W2123906548 @default.
- W2897898885 cites W2125068253 @default.
- W2897898885 cites W2130003736 @default.
- W2897898885 cites W2130010008 @default.
- W2897898885 cites W2133496985 @default.
- W2897898885 cites W2140013858 @default.
- W2897898885 cites W2140380746 @default.
- W2897898885 cites W2141067740 @default.
- W2897898885 cites W2143766145 @default.
- W2897898885 cites W2145809457 @default.
- W2897898885 cites W2147391835 @default.
- W2897898885 cites W2151935175 @default.
- W2897898885 cites W2152701478 @default.
- W2897898885 cites W2154713479 @default.
- W2897898885 cites W2159560463 @default.
- W2897898885 cites W2159753941 @default.
- W2897898885 cites W2162444234 @default.
- W2897898885 cites W2164503023 @default.
- W2897898885 cites W2337425434 @default.
- W2897898885 cites W2520601585 @default.
- W2897898885 cites W2603684637 @default.
- W2897898885 cites W2677663897 @default.
- W2897898885 cites W2740487222 @default.
- W2897898885 cites W2749286615 @default.
- W2897898885 cites W2750364489 @default.
- W2897898885 cites W2782998220 @default.
- W2897898885 cites W2804540340 @default.
- W2897898885 cites W2804680715 @default.
- W2897898885 cites W4249980792 @default.
- W2897898885 cites W4313333731 @default.